RECRUITING

Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*

Talk to us

Conditions

Idiopathic Toe WalkingGaitCastingSurgeryGenomicsMotor ControlStrengthBalance and Coordination

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To compare and contrast the clinical, gait and parent-reported outcomes following either non-operative (casting) or operative treatment for children with idiopathic toe walking (ITW) and determine whether there are specific genes associated with ITW.

Official Title

Defining Treatment Outcomes and Genetic Architecture in Idiopathic Toe Walking*

Quick Facts

Study Start:2022-01-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06305689

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:6 Years to 18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Diagnosis of Idiopathic Toe Walking Persistent (ITWp)
  2. 2. Between the ages of 6-18 years
  3. 3. Passive dorsiflexion dorsiflexion with knee extension between -10 plantar flexion - + 5 degrees of dorsiflexion, DiGiovanni defined an isolated gastrocnemius contracture as maximum passive ankle dorsiflexion as \< 5 degrees with the knee in full extension
  1. 1. Diagnosis of Autism or autism spectrum disorder
  2. 2. Presence of any indicators of trauma, neuromuscular influence or neurogenic influence as identified by using the Toe Walking Tool

Contacts and Locations

Study Contact

Paige Lemhouse
CONTACT
971-544-3377
plemhouse@shrinenet.org
Susan Sienko, PhD
CONTACT
503-221-3481
ssienko@shrinenet.org

Principal Investigator

Jeremy Bauer, MD
PRINCIPAL_INVESTIGATOR
Shriners Hospitals for Children-Portland

Study Locations (Sites)

Shriners Hospitals for Children
Sacramento, California, 95817
United States
Shriners Hospitals for Children
Chicago, Illinois, 60707
United States
Shriners Hospitals for Children
Lexington, Kentucky, 40508
United States
Shriners Hospitals for Children
Portland, Oregon, 97239
United States
Shriners Hospitals for Children
Philadelphia, Pennsylvania, 19140
United States
Shriners Hospitals for Children
Greenville, South Carolina, 29605
United States
Shriners Hospitals for Children
Salt Lake City, Utah, 84103
United States
Shriners Children's Spokane
Spokane, Washington, 99204
United States

Collaborators and Investigators

Sponsor: Shriners Hospitals for Children

  • Jeremy Bauer, MD, PRINCIPAL_INVESTIGATOR, Shriners Hospitals for Children-Portland

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-01-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2022-01-01
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • Idiopathic Toe Walking
  • Gait
  • Casting
  • Surgery
  • Genomics
  • Motor Control
  • Strength
  • Balance and Coordination

Additional Relevant MeSH Terms

  • Idiopathic Toe Walking